RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced that the Company has generated new data demonstrating corneal delivery of a fluorescent analog ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE